Anti-herpesvirus activities and cytotoxicities of 2-thiopyrimidine nucleoside analogues in vitro

Antiviral Chemistry and Chemotherapy

Volumn 10, Issue 4, 1999, Pages 195-209

  Shigeta, S ^a   Mori, S ^a   Kira, T ^a   Takahashi, K ^a   Kodama, E ^a   Konno, K ^a   Nagata, T ^b   Kato, H ^b   Wakayama, T ^b   Koike, N ^b   Saneyoshi, M ^c  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b Tsukuba Research Laboratory   (Japan)

^c TEIKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

2 Thiopyrimidine nucleoside; Cytotoxicity; Herpes simplex virus; Human cytomegalovirus; Varicella zoster virus

Indexed keywords

2' DEOXY 5 IODO 2 THIOURIDINE; NUCLEOSIDE ANALOG; PYRIMIDINE NUCLEOSIDE; THIOURACIL; TN 17; TN 31; TN 32; TN 44; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOBLAST; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; EMBRYO; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LUNG ALVEOLUS CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS REPLICATION;

EID: 0032773306     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029901000404     Document Type: Article

References (42)

1. Agris PF, Soll D & Seno T (1973) Biological function of 2-thiouridine in Escherichia coli glutamic acid transfer ribonucleic acid. Biochemistry 12:4331-4337.
2. Biron KK, Stanat SC, Sorrel JB, Fyfe JA, Keller PM, Lambe CU & Nelson DJ (1985) Metabolic activation of the nucleoside analog 9{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}guanine in human diploid fibroblasts infected with human cytomegalovirus. Proceedings of the National Academy of Sciences, USA 82:2473-2477.
3. Biron KK, Fyfe JA, Stanat SC, Leslie LK, Sorrell JB, Lambe CU & Coen DM (1986) A human cytomegalovirus mutant resistant to the nucleoside analog 9{[2-hydroxy-1-(hydroxymethyl)ethoxy]-methyl} guanine (BWB759) induces reduced levels of BWB759U triphosphate. Proceedings of the National Academy of Sciences, USA 83:8769-8773.
4. Bretner M, Kulikowski T, Dzik JM, Balinska M, Rode W & Shugar D (1993) 2-Thio derivatives of dUrd and 5-FIuoro-dUrd and their 5′-monophosphates: synthesis, interaction with tumor thymidylate synthase, and in vitro antitumor activity. Journal of Medicinal Chemistry 36:3611-3617.
5. Bretner M, Balinska M, Krawiec K, Kierdaszuk B, Shugar D & Kulikowski T (1995) Synthesis and biological activity of 5-fluoro-2-thiocytosine nucleosides. Nucleosides and Nucleotides 32:657-660.
6. Calabresi P, Cardosso SS, Finch SC, Kligermann MM, von Essen CF, Chu MY & Welch AD (1961) Initial clinical studies with 5-iodo-2′-deoxyuridine. Cancer Research 21:550-559.
7. Chow AW, Foerster J & Hryniuk W (1970) Cytosine arabinoside therapy for herpesvirus infections. Antimicrobial Agents and Chemotherapy 10:214-217.
8. Cook AF & Holman MJ (1978) Fluorinated pyrimidine nucleosides. 2. Reaction of 2,2′-anhydro-1-β-D-arabinofuranosyl-5-fluorocytosine hydrochloride with nitrogen and sulfur nucleophiles. Journal of Organic Chemistry 43:4200-4206.
9. Dawson WO & Grantham GL (1983) Effect of 2-thiouracil on RNA and protein synthesis in synchronous and asynchronous infections of tobacco mosaic virus. Intervirology 19:155-161.
10. De Clercq E, Descamps J, Velhalst G, Walker RJ, Jones AS, Torrence PF & Shugar D (1980) Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. Journal of Infectious Diseases 141:563-574.
11. De Clercq E, Descamps J, Ogata M & Shigeta S (1982) In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl,-2′-deoxyuridine and related compounds. Antimicrobial Agents and Chemotherapy 21:33-38.
12. Divakar KJ & Reese CB (1982) 4-(1,2,4-triazol-1-yl)-and 4-(3-nitro-1,2,4-triazol-1-yl)-1-(β-D-2,3,5-tri-O-acetylarabinofuranosyl) pyrimidine-2-(1H)-ones. Valuable intermediates in the synthesis of derivatives of 1-(β-D-arabinofuranosyl) cytosine (AraC). Journal of American Chemical Society 1:1171-1176.
13. Elion GB, Furman PA, Fyfe JA, De Miranda P, Beauchamp L & Schaeffer HJ (1977) Selectivity of action of an antiherpes agent, 9-(2-hydroxyethoxymethyl) guanine. Proceedings of the National Academy of Sciences, USA 74:5716-5720.
14. Erice A, Chou S, Biron KK, Stanat SC, Balfour HH Jr & Jordan MC (1989) Progressive disease due to ganciclovir resistant cytomegalovirus in immuno-compromised patients. New England of Journal of Medicine 320:289-293.
15. Felczak K, Bretner M, Balinska M, Golos B, Dzik JM, Rode W & Kulikowski T (1995) Synthesis and antitumor properties of 2-thio-5-chloro-nucleosides. Nucleosides and Nucleotides 14:653-656.
16. Gordon H (1994) Japan bans shingles drug after death. British Medical Journal 308:627-627.
17. Iigo M, Nishikata K, Nakajima Y, Hoshi A, Okudaira N, Odagiri H & De Clercq E (1989) Enhancing effect of bromovinyl deoxyuridine on antitumor activity of 5′-deoxy-5-fluorouridine against adenocarcinoma 755 in mice. Correlation with pharamcokinetics of plasma 5-fluorouracil levels. Biochemical Pharacology 38:1885-1888.
18. Kuhn CW (1977) Differential effect of 2-thiouracil on synthesis of two plant viruses in the same host. Intervirology 8:37-43.
19. Kuimelis RG, Hope H & Nambiar KP (1993) A stereoselective synthesis of α-and β-2′-deoxy-2-thiouridine. Nucleosides and Nucleotides 12:737-755.
20. Lin TS, Yang JH, Liu ZY, Chen YC, Prusoff WH, Brinbaum JI, Giziewicz J, Ghazzouli I, Brankovan V, Feng JS & Hsiung GD (1991) Synthesis and anticancer activity of various 3′-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-β-D-threo-pentofuranosyl)cytosine. Journal of Medicinal Chemistry 34:693-701.
21. Lindsay RH & Yu MW (1974) Inhibitory effect of 2-thiouracil and 2-thiouracil metabolites on enzymes involved in pyrimidine nucleoside biosynthesis. Biochemical Pharmacology 23:2273-2281.
22. Machida H, Kuninaka A & Yoshino H (1982) Inhibitory effects on antiviral thymidine analogs against varicella-zoster virus. Antimicrobial Agents and Chemotherapy 21:358-361.
23. Mitchell CD, Bean B, Gentry SR, Groth KE, Boen JR & Balfour HH Jr (1981) Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet i:1389-1392.
24. Napolitano A, Palumbo A, d'Ishcia M & Prota G (1996) Mechanism of selective incorporation of the melanoma seeker 2-thiouracil into growing melanin. Journal of Medicinal Chemistry 39:5192-5201.
25. Nawrot B & Malkiewicz A (1989) The tRNA 'wobble position' uridines. III. The synthesis of 5-[S-methoxycarbonyl-(hydroxy)methyl]uridine and its 2-thio analogues. Nucleosides and Nucleotides 8:1499-1512.
26. Ohashi Z, Saneyoshi M, Harada F, Hara H & Nishimura S (1970) Presumed anticodon structure of glutamic acid tRNA from E. coli: a possible location of a 2-thiouridine derivative in the first position of the anticodon. Biochemical and Biophysical Research Communications 40:866-872.
27. Palumbo A, Napolitano A, De Martino L, Vieira W, Hearing VJ (1994) Specific incorporation of 2-thiouracil into biological melanins. Biochimica et Biophysica Acta 1200:271-276.
28. Prusoff WH (1988) Idoxuridine or how it all began. In Clinical Use of Antiviral Drugs, pp. 15-24. Edited by E De Clercq. Boston: Martinus Nijhoff Publishing.
29. Ralph RK & Wojcik SJ (1976) Inhibition of turnip yellow mosaic virus synthesis by pyrimidine analogues. Biochimica et Biophysica Acta 444:261-268.
30. Ruyle WV & Shen TY (1967) Nucleosides. V. 2-thiopyrimidine-β-D-arabinofuranosides. Journal of Medicinal Chemistry 10:331-334.
31. Sekiya T & Ukita T (1967) Some attempts on substitution of 2′-position of uridine with thiol group. Chemical and Pharmaceutical Bulletin 15:1498-1502.
32. LYS. Nucleic Acids Research 3:523-534.
33. Shigeta S, Yokota T, Iwabuchi M, Baba M, Konno K, Ogata M & De Clercq E (1983) Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus. Journal of Infectious Diseases 147:576-584.
34. Shigeta S, Konno K, Yokota T, Nakamura K & De Clercq E (1988) Comparative activities of several nucleoside analogs against influenza A, B & C viruses in vitro. Antimicrobial Agents and Chemotherapy 32:906-911.
35. Shigeta S, Konno K, Baba M, Yokota T & De Clercq E (1991) Comparative inhibitory effects of nucleoside analogs on different clinical isolates of human cytomegalovirus in vitro. Journal of Infectious Diseases 163:270-275.
36. Steel FM & Black FL (1967) Inactivation and heat stabilization of poliovirus by 2-thiouracil. Journal of Virology 1:653-658.
37. Stevens DA, Jordan GW, Waddall TP & Merigan TC (1973) Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial. New England Journal of Medicine 289:873-878.
38. Glu is a positive determinant for aminoacylation by Escherichia coli glutamyl-tRNA synthetase. Biochemistry 32:3836-3841.
39. Vorbruggen H & Strehlke P (1973) Eine einfache synthese von 2-thiopyrimidin-nucleosiden; Chemie Berlin 106:3039-3061.
40. Wade JC, MaGuffin RW, Springmeyer SC, Newton B, Singer JW & Meyers JD (1983) Treatment of cytomegaloviral pneumonia with high-dose acyclovir and human leukocyte interferon. Journal of Infectious Diseases 148:557-562.
41. Watjen F, Buchardt O & Langvad E (1982) Affinity therapeutics. 1. Selective incorporation of 2-thiouracil derivatives in murine melanomas. Cytostatic activity of 2-thiouracil arotinoids, 2-thiouracil retinoids, arotinoids, and retinoids. Journal of Medicinal Chemistry 25:956-960.
42. Yu MW, Sedlak J & Lindsay RH (1973) Negative antithyroid effects of 2-thiouracil, 2-thiouridine and 2-thio-UMP. Proceedings of the Society for Experimental Biology and Medicine 143:672-676.